| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| GTO ID | GTC0192 |
| Trial ID | NCT02062359 |
| Disease | Metastatic Melanoma |
| Altered gene | NY-ESO-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | NY-ESO-1 TCR-T cells |
| HLA | HLA-A*02:01 |
| Phase | Phase2 |
| Recruitment status | Terminated |
| Title | Phase II Study of CD62L+-Derived T Lymphocytes Transduced With a T Cell Receptor Recognizing the NY-ESO-1 Antigen and Aldesleukin Following Lymphodepletion in Patients With NY-ESO-1 Expressing Melanoma |
| Year | 2014 |
| Country | United States |
| Company sponsor | National Cancer Institute (NCI) |
| Other ID(s) | 140058|14-C-0058 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||||||
|
|||||||||||||||